|
Categories
Pharmaceutical Company
Pharmaceutical Sales
Pharmaceutical
Distributor
Pharmaceutical
Preparation
Pharmaceutical
Jobs
Pharmaceutical
Industry
Pharmaceutical
Drug
Pharmaceutical
Sales Jobs
Pharmaceutical
Product
Pharmaceutical
News
Pharmaceutical
Research
Pharmaceutical
Manufacturer
Pharmaceutical Sales
Rep
Pharmaceutical
Sales Resume
Pharmaceutical
Online
Pharmaceutical
Marketing
Pharmaceutical
Dictionary
Pharmaceutical
Recruiter
Pharmaceutical
Supply
Pharmaceutical
Technology
Pharmaceutical
Advertising
Pharmaceutical
Schools
Companies
Pfizer Pharmaceutical
Wyeth Pharmaceutical
Watson Pharmaceutical
Merck Pharmaceutical
Roche Pharmaceutical
King Pharmaceutical
Teva Pharmaceutical
Aventis
Pharmaceutical
Novartis
Pharmaceutical
Forest
Pharmaceutical
Tap
Pharmaceutical
Shire
Pharmaceutical
Mayne
Pharmaceutical
Millennium
Pharmaceutical
Lilly
Pharmaceutical
Mylan
Pharmaceutical
Kos
Pharmaceutical
Takeda
Pharmaceutical
Endo
Pharmaceutical
Janssen
Pharmaceutical
Barr
Pharmaceutical
Abbott
Pharmaceutical
Reliant
Pharmaceutical
Solvay
Pharmaceutical
Amylin
Pharmaceutical
Vertex
Pharmaceutical
Osi
Pharmaceutical
Bayer
Pharmaceutical
Voyager
Pharmaceutical
Mcneil
Pharmaceutical
Boehringer
Ingelheim
Astra
Zeneca Pharmaceutical
Glaxosmithkline
Pharmaceutical
Novo Nordisk
Pharmaceutical
3m
Pharmaceutical
Eli
Lilly Pharmaceutical
Elan Pharmaceutical
Ivax
Pharmaceutical
Search engines:
Google
Lycos
AltaVista
Yahoo
Mirago
Ask
Teoma
Excite |
|
|
|
Endo Pharmaceuticals
 Endo
Pharmaceuticals
Endo became Endo Pharmaceuticals Inc. (NASDAQ: ENDP)
as a result of a management buyout from DuPont Merck in 1997. Endo
Pharmaceuticals are a specialty pharmaceutical company engaged in the research,
development, sale and marketing of prescription pharmaceuticals used primarily
to treat and manage pain.
Endo Pharmaceuticals are a specialty
pharmaceutical company with market leadership in pain management. Endo
Pharmaceuticals are engaged in the research, development, sale and marketing of
branded and generic prescription pharmaceuticals used primarily to treat and
manage pain. According to IMS Health data, the total U.S. market for pain
management pharmaceuticals, excluding over-the-counter products, totaled $18.9
billion in 2004. This represents an approximately 16% compounded annual growth
rate since 2000. Endo Pharmaceuticals primary area of focus within this market
is in the opioid analgesics segment. Total U.S. sales for this segment were
estimated to be $6.3 billion in 2004, representing a compounded annual growth
rate of 20% since 2000.
Endo Pharmaceuticals have a portfolio of
branded, marketed products that includes established brand names such as
Lidoderm® (lidocaine patch 5%), Percocet® (oxycodone and acetaminophen
tablets USP) CII, and Percodan® (oxycodone and aspirin tablets, USP) CII,
as well as newer products Frova® (frovatriptan succinate) tablets and
DepoDur® (morphine sulfate extended-release liposome injection). Branded
products comprised approximately two-thirds of our net sales in 2004. Our
generic portfolio, which accounted for about one-third of net sales in 2004,
consists of products that cover a variety of indications, most of which are
focused in pain management. We focus on generics that have one or more barriers
to market entry, such as complex formulation, regulatory or legal challenges or
difficulty in raw material sourcing.
Endo Pharmaceuticals have
established research and development expertise in analgesics and devote
significant resources to this effort so that they can maintain and develop
their product pipeline. Endo Pharmaceuticals late-stage branded product
pipeline includes two filed NDAs and seven products in Phase III or Phase II
clinical trials.
Through an internal sales force of approximately 370
sales representatives in the United States, Endo Pharmaceuticals market their
branded pharmaceutical products to high-prescribing physicians in pain
management, surgery, oncology, anesthesiology and primary care. Endo
Pharmaceuticals sales force also targets retail pharmacies and other healthcare
professionals throughout the United States.
Endo Pharmaceuticals -
further information
http://www.endo.com/
|
|
|
|
|
